Poliovirus research has reached the point where molecular biologists and those interested in control of the disease can profitably come together. New molecular approaches offer the opportunity to make vaccines by previously inconceivable routes. These include synthesis of antigenic proteins in bacteria and chemical synthesis of antigenic peptides.